Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and bc 264

3,4-dihydroxyphenylacetic acid has been researched along with bc 264 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daugé, V; Keller, G; Ladurelle, N; Roques, BP1
Blommaert, A; Daugé, V; Keller, G; Ladurelle, N; Roques, BP1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and bc 264

ArticleYear
Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Brain research, 1993, Nov-19, Volume: 628, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Sequence; Amphetamine; Animals; Cholecystokinin; Dopamine; Homovanillic Acid; Male; Microdialysis; Molecular Sequence Data; Motor Activity; Nucleus Accumbens; Peptide Fragments; Perfusion; Rats; Rats, Wistar; Sincalide

1993
The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
    The European journal of neuroscience, 1997, Volume: 9, Issue:9

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Attention; Cholecystokinin; Dopamine; Dopamine Antagonists; Exploratory Behavior; Homovanillic Acid; Injections, Intraperitoneal; Male; Maze Learning; Motivation; Nucleus Accumbens; Peptide Fragments; Rats; Rats, Wistar; Receptors, Cholecystokinin

1997